Cargando…

Does MRI have added value in ultrasound-detected BIRADS-3 breast masses in candidates for assisted reproductive therapy?

BACKGROUND: Ultrasound-detected breast lesions with probably benign features are a great challenge for clinicians, especially in breasts with dense composition. We aimed to investigate the finding of two radiologic modalities on these lesions. METHODS: This retrospective cross-sectional study recrui...

Descripción completa

Detalles Bibliográficos
Autores principales: Arian, Arvin, Delazar, Sina, Aghasi, Maryam, Jahanbin, Behnaz, Ahmadinejad, Nasrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823155/
https://www.ncbi.nlm.nih.gov/pubmed/36624818
http://dx.doi.org/10.1016/j.ejro.2022.100474
_version_ 1784866093275283456
author Arian, Arvin
Delazar, Sina
Aghasi, Maryam
Jahanbin, Behnaz
Ahmadinejad, Nasrin
author_facet Arian, Arvin
Delazar, Sina
Aghasi, Maryam
Jahanbin, Behnaz
Ahmadinejad, Nasrin
author_sort Arian, Arvin
collection PubMed
description BACKGROUND: Ultrasound-detected breast lesions with probably benign features are a great challenge for clinicians, especially in breasts with dense composition. We aimed to investigate the finding of two radiologic modalities on these lesions. METHODS: This retrospective cross-sectional study recruited patients including (1) candidates of assisted reproductive therapy (ART), (2) patients with prior high-risk lesions, and (3) the “suspected” BIRADS-3 masses referring to masses that US BIRADS-3 was not compatible with the clinical breast exam. The degree of agreement in diagnosing BIRADS-3 lesions between two modalities of magnetic resonance imaging (MRI) and ultrasonography (US), and comparison of the lesions in US and MRI were the study variables. RESULTS: A total number of 123 lesions in 67 patients with a median age of 38 (IQR: 11, range: 17–67). In the examination by MRI, 107 (87.0 %) lesions were BIRADS-3 indicating the agreement level between these two modalities. The median size of the lesions in US was 9 mm (IQR: 5, range: 3–43) and 9 mm (IQR: 10, range: 4–46) in MRI. The measured size of the lesions between the two modalities was highly correlated (Spearman correlation coefficient: 0.889, P-value < 0.001). MRI evaluation revealed two cases of deep lesions which were missed in the US imaging. CONCLUSIONS: This study found relatively high agreement values between US and MRI in detecting BIRADS-3 breast lesions in candidates for ART or patients with prior high-risk lesions. Also, MRI could downgrade about one-tenth of the cases to a lower BIRADS level and resolved the need for closer follow-up.
format Online
Article
Text
id pubmed-9823155
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-98231552023-01-08 Does MRI have added value in ultrasound-detected BIRADS-3 breast masses in candidates for assisted reproductive therapy? Arian, Arvin Delazar, Sina Aghasi, Maryam Jahanbin, Behnaz Ahmadinejad, Nasrin Eur J Radiol Open Original Article BACKGROUND: Ultrasound-detected breast lesions with probably benign features are a great challenge for clinicians, especially in breasts with dense composition. We aimed to investigate the finding of two radiologic modalities on these lesions. METHODS: This retrospective cross-sectional study recruited patients including (1) candidates of assisted reproductive therapy (ART), (2) patients with prior high-risk lesions, and (3) the “suspected” BIRADS-3 masses referring to masses that US BIRADS-3 was not compatible with the clinical breast exam. The degree of agreement in diagnosing BIRADS-3 lesions between two modalities of magnetic resonance imaging (MRI) and ultrasonography (US), and comparison of the lesions in US and MRI were the study variables. RESULTS: A total number of 123 lesions in 67 patients with a median age of 38 (IQR: 11, range: 17–67). In the examination by MRI, 107 (87.0 %) lesions were BIRADS-3 indicating the agreement level between these two modalities. The median size of the lesions in US was 9 mm (IQR: 5, range: 3–43) and 9 mm (IQR: 10, range: 4–46) in MRI. The measured size of the lesions between the two modalities was highly correlated (Spearman correlation coefficient: 0.889, P-value < 0.001). MRI evaluation revealed two cases of deep lesions which were missed in the US imaging. CONCLUSIONS: This study found relatively high agreement values between US and MRI in detecting BIRADS-3 breast lesions in candidates for ART or patients with prior high-risk lesions. Also, MRI could downgrade about one-tenth of the cases to a lower BIRADS level and resolved the need for closer follow-up. Elsevier 2022-12-30 /pmc/articles/PMC9823155/ /pubmed/36624818 http://dx.doi.org/10.1016/j.ejro.2022.100474 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Article
Arian, Arvin
Delazar, Sina
Aghasi, Maryam
Jahanbin, Behnaz
Ahmadinejad, Nasrin
Does MRI have added value in ultrasound-detected BIRADS-3 breast masses in candidates for assisted reproductive therapy?
title Does MRI have added value in ultrasound-detected BIRADS-3 breast masses in candidates for assisted reproductive therapy?
title_full Does MRI have added value in ultrasound-detected BIRADS-3 breast masses in candidates for assisted reproductive therapy?
title_fullStr Does MRI have added value in ultrasound-detected BIRADS-3 breast masses in candidates for assisted reproductive therapy?
title_full_unstemmed Does MRI have added value in ultrasound-detected BIRADS-3 breast masses in candidates for assisted reproductive therapy?
title_short Does MRI have added value in ultrasound-detected BIRADS-3 breast masses in candidates for assisted reproductive therapy?
title_sort does mri have added value in ultrasound-detected birads-3 breast masses in candidates for assisted reproductive therapy?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823155/
https://www.ncbi.nlm.nih.gov/pubmed/36624818
http://dx.doi.org/10.1016/j.ejro.2022.100474
work_keys_str_mv AT arianarvin doesmrihaveaddedvalueinultrasounddetectedbirads3breastmassesincandidatesforassistedreproductivetherapy
AT delazarsina doesmrihaveaddedvalueinultrasounddetectedbirads3breastmassesincandidatesforassistedreproductivetherapy
AT aghasimaryam doesmrihaveaddedvalueinultrasounddetectedbirads3breastmassesincandidatesforassistedreproductivetherapy
AT jahanbinbehnaz doesmrihaveaddedvalueinultrasounddetectedbirads3breastmassesincandidatesforassistedreproductivetherapy
AT ahmadinejadnasrin doesmrihaveaddedvalueinultrasounddetectedbirads3breastmassesincandidatesforassistedreproductivetherapy